Cargando…
The need to implement non-industry COVID-19 clinical trials in non-high-income countries
Autores principales: | Dal-Ré, Rafael, Carcas, Antonio J, Sreeharan, Nadarajah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Society of Global Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7242883/ https://www.ncbi.nlm.nih.gov/pubmed/32509284 http://dx.doi.org/10.7189/jogh.10.010351 |
Ejemplares similares
-
Establishing a novel partnership model to deploy health services for children with autism in a low-resource setting – experience from Sri Lanka
por: Sivayokan, Bhavana, et al.
Publicado: (2023) -
“Let me choose my COVID-19 vaccine”
por: Dal-Ré, Rafael, et al.
Publicado: (2021) -
Continuum of care approach for managing non-communicable diseases in low- and middle-income countries
por: Thapa, Rajshree, et al.
Publicado: (2020) -
Access to palliative care: discrepancy among low-income and high-income countries
por: Poudel, Arjun, et al.
Publicado: (2019) -
Protections for clinical trials in low and middle income countries need strengthening not weakening
por: Dal-Ré, Rafael, et al.
Publicado: (2014)